Data from this study provides new country specific reference ranges which should be immediately adopted for routine clinical care and accurate monitoring of adverse events in research studies.
No takes yet. Share an insight, caveat, or question.
Samaneka et al. (2016) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: